Cancer Alternative Treatment 53 / Coley Fluid

Cancer Alternative Treatment 53 / Coley Fluid ( Coley Toxins)

In 1891, William Coley of New York’s Memorial Hospital developed the most effective single-agent anticancer therapy in the medical literature. It is not in general use today due to a very effective negative propaganda effort within the medical-industrial-regulatory complex of the 1960s, and a lack of contemporary initiative to undo the damage: “There is no question that inappropriate judgments have resulted in injury to good observations: if we look at Coley’s toxins, a turn-of-the-century pyrogenic bacterial endotoxin anti-cancer treatment, we see a valid approach to nonspecific host resistance set back by being falsely labeled a ‘quack remedy’ by the American Cancer Society.” (William Regelson. Journal of the American Medical Association. 1980;243(4):337-339).

The five-year survival rates for advanced, inoperable cancers of the breast, ovary, cervix, and uterus, as well as giant cell bone sarcoma and Hodgkin’s lymphoma met or exceeded two thirds of all patients treated with Coley Fluid (Coley’s toxins) alone. For inoperable melanoma, the five-year survival rate was a remarkable 60%. (Helen Nauts. Cancer Research Institute Monograph No. 18:1984).

These survival rates are all the more remarkable in light of the fact that Coley did not attempt to adjust for many variables, such as nutritional status of the patient, immune competence, negative influences like liquor, tobacco, etc. Further, there were no antibiotics in his time, no heart drugs, no blood pressure drugs, not even insulin (until 1922). Coley simply injected his vaccine (Coley’s toxins) repeatedly.

Stephen Hoption-Cann of the University of British Columbia recently wrote: “Despite the ‘crude’ approach taken by Coley, his vaccine stimulated a complex immune response that could induce the complete regression of both extensive primary and metastatic lesions. Furthermore, his vaccine was universally effective against many types of malignancies. Tumors that were observed to partially or completely regress following treatment with Coley’s vaccine included: lymphomas, melanomas, myelomas, sarcomas and a wide spectrum of carcinomas.” (Medical Hypotheses. 2002;58(2):115-119). In the same article, Hoption-Cann lamented the fact that standardized cancer management not only fails to consistently produce lasting cures, it has in all likelihood reduced the number of non-treatment-related remissions of the disease: “Modern approaches to treatment have reduced the occurrence of spontaneous regressions. Aseptic techniques and antibiotics significantly reduce postoperative infections, while chemotherapy and radiation impair immune activation even when an infection does occur.”